Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRDN
12251
PUT
Meridian Holdings Inc
MRDN
$181M
| $24K | ﹤0.01% |
+2,500
| New | +$27.3K |
|
12252
Origin Agritech
SEED
$12.1M
| $24K | ﹤0.01% |
+21,602
| New | +$31.8K |
|
12253
PUT
AirSculpt Technologies
AIRS
$350M
| $24K | ﹤0.01% |
12,100
-16,000
| -57% | -$97.1K |
|
|
HIT
12254
Health In Tech Inc
HIT
$74.7M
| $23.9K | ﹤0.01% |
+15,043
| New | +$32.8K |
|
|
RMSG
12255
Real Messenger Corp
RMSG
$5.43M
| $23.9K | ﹤0.01% |
17,669
-1,154
| -6% | -$2.31K |
|
|
CIF
12256
DELISTED
MFS Intermediate High Income Fund
CIF
| $23.8K | ﹤0.01% |
+13,996
| New | +$24.2K |
|
12257
PUT
Lineage Cell Therapeutics
LCTX
$279M
| $23.7K | ﹤0.01% |
14,200
-6,700
| -32% | -$11.6K |
|
12258
CALL
Standard BioTools
LAB
$321M
| $23.7K | ﹤0.01% |
18,500
-27,000
| -59% | -$36.3K |
|
12259
Birks Group
BGI
$9.78M
| $23.7K | ﹤0.01% |
+26,292
| New | +$28.6K |
|
|
ZDAI
12260
DirectBooking Technology Co
ZDAI
$13.7M
| $23.5K | ﹤0.01% |
7,201
+5,437
| +308% | +$36.7K |
|
12261
PUT
Traeger
COOK
$191M
| $23.4K | ﹤0.01% |
+434
| New | +$21.1K |
|
|
SLXN
12262
Silexion Therapeutics
SLXN
$2.02M
| $23.4K | ﹤0.01% |
+1,221
| New | +$36.7K |
|
12263
PUT
SelectQuote
SLQT
$131M
| $23.4K | ﹤0.01% |
16,600
+5,000
| +43% | +$8.36K |
|
12264
Catheter Precision
VTAK
$996K
| $23.4K | ﹤0.01% |
+12,771
| New | +$29.4K |
|
|
ICON
12265
Icon Energy
ICON
$3.81M
| $23.3K | ﹤0.01% |
6,955
-2,049
| -23% | -$12.8K |
|
12266
CALL
Hyliion Holdings
HYLN
$729M
| $23.2K | ﹤0.01% |
12,600
-13,300
| -51% | -$26.8K |
|
12267
CALL
C4 Therapeutics
CCCC
$399M
| $23.1K | ﹤0.01% |
+12,100
| New | +$28.7K |
|
12268
Pop Culture Group
CPOP
$4.45M
| $22.9K | ﹤0.01% |
+5,450
| New | +$32.7K |
|
|
RVPH
12269
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $22.8K | ﹤0.01% |
4,085
+3,180
| +351% | +$35.4K |
|
12270
CALL
Heron Therapeutics
HRTX
$96.8M
| $22.6K | ﹤0.01% |
+17,400
| New | +$21.5K |
|
12271
New Concept Energy
GBR
$3.46M
| $22.6K | ﹤0.01% |
30,239
-3,929
| -11% | -$3.36K |
|
12272
HF Foods Group
HFFG
$79.1M
| $22.5K | ﹤0.01% |
+10,469
| New | +$25.2K |
|
12273
PUT
Neumora Therapeutics
NMRA
$296M
| $22.2K | ﹤0.01% |
12,400
-31,300
| -72% | -$68.5K |
|
12274
CALL
PMV Pharmaceuticals
PMVP
$62.4M
| $22.1K | ﹤0.01% |
+17,700
| New | +$23.7K |
|
|
SDM
12275
DELISTED
Smart Digital Group
SDM
| $22.1K | ﹤0.01% |
15,939
| – | – |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.